Orbimed Advisors - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAD4. A total of 35 filers reported holding BRIDGEBIO PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q2 2023$9,265,350
-27.9%
15,000,000
-25.0%
0.17%
-33.3%
Q1 2023$12,853,200
+2.0%
20,000,000
-33.3%
0.25%
+4.6%
Q4 2022$12,600,000
+0.7%
30,000,0000.0%0.24%
+3.9%
Q3 2022$12,509,000
+3.0%
30,000,0000.0%0.23%
+5.5%
Q2 2022$12,150,000
-15.7%
30,000,0000.0%0.22%
-6.0%
Q1 2022$14,416,00030,000,0000.23%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Diameter Capital Partners LP 52,257,000$39,745,1068.72%
Context Capital Management, LLC 32,083$24,0521.93%
BRAIDWELL LP 67,294,000$50,470,5001.60%
DeepCurrents Investment Group LLC 17,855,000$13,514,0560.59%
Aequim Alternative Investments LP 20,000,000$15,000,0000.57%
ADVENT CAPITAL MANAGEMENT /DE/ 29,488,000$22,116,0000.51%
SILVERBACK ASSET MANAGEMENT LLC 5,000,000$3,750,3750.51%
ARISTEIA CAPITAL, L.L.C. 25,280,000$18,960,0000.51%
SSI INVESTMENT MANAGEMENT LLC 8,217,000$6,121,6650.50%
ABSOLUTE INVESTMENT ADVISERS, LLC 4,604,000$3,430,5200.49%
View complete list of BRIDGEBIO PHARMA INC shareholders